1. Girardi M, Heald PW, Wilson LD. Receptor
gamma gene rearrangements in early. The pathogenesis
of mycosis fungoides. N Engl J 2004; 48: 23–30.
2. Kazakov DV, Burg G, Kempf W. Clinicopathological
spectrum of MF. J Invest Dermatol 2004; 119:
1405–10.
3. Leboit PE, McCalmont TH. Cutaneous the skin
at different stages of mycosis fungoides. T-cell clonality
detection in mycosis fungoides by lymphomas and
leukemias. Lever’s 1997.
4. Kim YH et al. Long-term outcome of 525 patients
with MF and SS: clinical prognostic factors and risk
for disease progression. Arch Dermatol 2003; 139:
857–66.
5. Галил-Оглы Г.А., Молочков В.А., Сергеев Ю.В.
Дерматоонкология. М.: Медицина для всех, 2005;
с. 481–620, 628–34.
6. Diamandidou E, Colome-Grimmer M, Fayad L
et al. Transformation of mycosis fungoides/Sezary
syndrome: clinical characteristics and prognosis. Blood
1998; 92: 1150–9.
7. Ярилин А.А. Иммунологические функции
кожи. Вестн. эстетич. мед. 2009; 8 (2): 72–7.
8. Королькова Т.Н. Иммунный надзор и опухо-
левая прогрессия при лимфомах кожи низкой
степени злокачественности: Автореф. ... дис.
д-ра мед. наук. СПб., 1996.
9. Kim EJ, Hess S, Richardson SK et al. Immunopathogenesis
and therapy of cutaneous T-cell lymphoma.
J Clin Inv 2005; 115 (5): 798–812.
10. Berger CL et al. The growth of cutaneous T-cell
lymphoma is stimulated y immature dendritic cells.
Blood 2002; 99: 2929–39.
11. Сидорова Ю.В. Т-клеточная клональность
в диагностике лимфопролиферативных заболе-
ваний. Автореф. ... канд. мед. наук. М., 2004.
12. Curco N, Servitje O, Llucia M et al. Genotypic
analysis of cutaneous T-cell lymphoma: a comparative
study of southern blot analysis with polymerase chain
reaction amplification of the T-cell receptor-gamma
gel. Br J Dermatol 1997; 137: 673–9.
13. Fisher SG, Fisher RI. The epidemitic implications.
Arch Dermatol 2004; 132: 42–7.
14. Никитин Е.А., Ленива Е.А., Судариков А.Б.
Роль молекулярных методов в диагностике и
мониторинге лимфопролиферативных заболева-
ний.
15. Лезвинская Е.М., Кильдюшевский А.В., Гуре-
вич Л.Е. и др. Современные методы диагностики
и лечения больных злокачественными лимфома-
ми кожи. Пособие для врачей. М., 2005.
16. Willemze R, Jaffe ES, Burg G et al. WHOEORTC
classification for cutaneous lymphomas. Blood
2005; 105: 3768–85.
17. Massone C, Kodama K, Kerl H, Cerroni L. Histopathologic
features of early (patch) lesions of mycosis
fungoides: a morphologic study on 745 biopsy
specimens from 427 patients. Am J Surg Pathol 2005;
29: 550–60.
18. Nickoloff BJ. Light-microscopic assessment of
100 patients with patch/plaque-stage mycosis fungoides.
Am J Dermatopathol 1988; 10: 469–77.
19. Cerroni L, Rieger E, Hodl S, Kerl H. Clinicopathologic
and immunologic features associated with
transformation of mycosis fungoides to large-cell lymphoma.
Am J Surg Pathol 1992; 16: 543–52.
20. Vermeer MH, Geelen FA, Kummer JA et al.
Expression of cytotoxic proteins by neoplastic T cells
in mycosis fungoides increases with progression from
plaque stage to tumor stage disease. Am J Pathol 1999;
154: 1203–10.
21. Smoller BR, Santucci M, Wood GS, Whittaker
SJ. Histopathology and genetics of cutaneous T-cell
lymphoma. Hematol Oncol Clin North Am 2003; 17:
1277–311.

Г.В.Овсянникова
ГУ МОНИКИ им. М.Ф.Владимирского